Rocket Lab Corp. (RKLB)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-04
$64.26+0.71%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-04
Warn: Management is running behind on a stated commitment.
Rocket Lab aims for $225M-$240M revenue in Q2 2026. Gross margins target 33%-35% next quarter. The Iridium deal boosts revenue and vertical integration. Losses should shrink toward a $20M-$26M adjusted EBITDA loss in Q2.
Rocket Lab still loses money and missed past profit targets. CEO's stake sale raises leadership concerns. The new rocket is untested and may delay growth. Profit loss may stay worse than planned.
The price is about 26% below our fair value near $112. Analysts expect 54% revenue growth. We agree with this growth but see risks in profit and leadership.
Breaks if: CEO sells large stake or leadership doubts rise
Breaks if: Adjusted EBITDA loss exceeds $26 million in Q2 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a speculative growth investment with a focus on long-term execution. The current thesis state is cautious, given the company's recent volatility and loss-making status.
The market seems to have priced in a justified valuation, but there is a significant expectations gap. Rocket Lab is currently seen as more expensive compared to its peers, reflecting uncertainty about its future performance.
Fundamentals may remain weak in the near term due to high risk and recent financial performance that lags behind industry peers. However, management's focus on revenue growth and backlog expansion could provide some positive momentum.
The long-term thesis hinges on the successful completion of key acquisitions and the ability to maintain revenue growth. Additionally, the performance of sector bellwethers will be crucial in determining the overall market sentiment.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. Rocket Lab secured significant contracts, boosting revenue outlook. The company is now part of the U.S. Space Force's NITE-STAR program. This program has a ceiling of up to $981 million. The Neutron rocket's launch has been delayed to the fourth quarter. Despite this, the overall revenue growth and backlog expansion are positive signs.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Gross margin falls below 33% in Q2 2026
Maintain disciplined cost management to achieve targeted GAAP gross margins in the second quarter of 2026.
Stated as a priority in 2 quarters, 2026-Q1 and 2026-Q2. GAAP gross margin was 36.1% in 2026-Q1 and guided between 33% and 35% for 2026-Q2. The company is maintaining disciplined cost management with margins consistent with guidance, indicating delivering trajectory.
“GAAP gross margins guidance between 33% and 35% for Q2 2026.”
“GAAP gross margins guidance between 34% and 36% for Q1 2026.”
Breaks if: Revenue falls below $225 million in Q2 2026
In the next 1 to 3 years, Rocket Lab's success will depend on its execution of strategic priorities amid a challenging environment. Not investment advice.